Skip to main content
Erschienen in: Quality of Life Research 3/2010

01.04.2010

Psychometric properties of the EQ-5D in a study of people with mild to moderate dementia

verfasst von: Simone Kunz

Erschienen in: Quality of Life Research | Ausgabe 3/2010

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Due to their cognitive impairment, the health-related quality of life (HRQoL) of patients with dementia is often rated by proxies. This study aims to analyse the psychometric properties of the EQ-5D applied to patients with mild to moderate dementia and their family caregivers.

Methods

Three hundred and ninety patients and their caregivers were asked to assess the patients’ HRQoL using the EQ-5D. The German population-based time trade-off values were used to calculate utility weights. Acceptance, discriminative ability, construct validity, inter-rater agreement and responsiveness were tested. Factors that could have an impact on inter-rater agreement were analysed using a multivariate regression.

Results

Five per cent of patients did not fill out the EQ-5D. The response rate of caregivers and of patients with mild dementia was higher than that of patients with moderate dementia. There were no floor or ceiling effects. The test results of the caregivers concerning construct validity and responsiveness were better than those of the patients. The inter-rater reliability was not satisfactory either on the dimension level or on the utility score level. Caregivers gave the patients’ HRQoL significantly lower ratings than did the patients themselves. Better abilities of the patient to perform activities of daily living and a lower subjective burden of the caregiver were associated with a higher inter-rater agreement.

Conclusions

The study showed that the EQ-5D is especially applicable to patients with mild dementia and their caregivers as proxies. However, there are important differences between patient and proxy ratings, even in cases of mild dementia, at the dimension level as well as utility score level, which should be considered in the interpretation of quality of life scores.
Literatur
1.
Zurück zum Zitat Bickel, H. (2008). Das Wichtigste—Die Epidemiologie der Demenz. Berlin: Deutsche Alzheimer Gesellschaft. Bickel, H. (2008). Das Wichtigste—Die Epidemiologie der Demenz. Berlin: Deutsche Alzheimer Gesellschaft.
2.
Zurück zum Zitat Callahan, C. M., Boustani, M. A., Unverzagt, F. W., Austrom, M. G., Damush, T. M., Perkins, A. J., et al. (2006). Effectiveness of collaborative care for older adults with Alzheimer disease in primary care: A randomized controlled trial. Journal of the American Medical Association, 295(18), 2148–2157.CrossRefPubMed Callahan, C. M., Boustani, M. A., Unverzagt, F. W., Austrom, M. G., Damush, T. M., Perkins, A. J., et al. (2006). Effectiveness of collaborative care for older adults with Alzheimer disease in primary care: A randomized controlled trial. Journal of the American Medical Association, 295(18), 2148–2157.CrossRefPubMed
3.
Zurück zum Zitat Spijker, A., Vernooij-Dassen, M., Vasse, E., Adang, E., Wollersheim, H., Grol, R., et al. (2008). Effectiveness of nonpharmacological interventions in delaying the institutionalization of patients with dementia: A meta-analysis. Journal of the American Geriatrics Society, 56(6), 1116–1128.CrossRefPubMed Spijker, A., Vernooij-Dassen, M., Vasse, E., Adang, E., Wollersheim, H., Grol, R., et al. (2008). Effectiveness of nonpharmacological interventions in delaying the institutionalization of patients with dementia: A meta-analysis. Journal of the American Geriatrics Society, 56(6), 1116–1128.CrossRefPubMed
4.
Zurück zum Zitat Clegg, A., Bryant, J., Nicholson, T., McIntyre, L., De Broe, S., Gerard, K., et al. (2001). Clinical and cost-effectiveness of donepezil, rivastigmine and galantamine for Alzheimer’s disease: A rapid and systematic review. Health Technology Assessment, 5(1), 1–137. Clegg, A., Bryant, J., Nicholson, T., McIntyre, L., De Broe, S., Gerard, K., et al. (2001). Clinical and cost-effectiveness of donepezil, rivastigmine and galantamine for Alzheimer’s disease: A rapid and systematic review. Health Technology Assessment, 5(1), 1–137.
5.
Zurück zum Zitat The EuroHRQoL Group. (1990). EuroHRQoL—a new facility for the measurement of health-related quality of life. The EuroHRQoL Group. Health Policy, 16(3), 199–208.CrossRef The EuroHRQoL Group. (1990). EuroHRQoL—a new facility for the measurement of health-related quality of life. The EuroHRQoL Group. Health Policy, 16(3), 199–208.CrossRef
6.
Zurück zum Zitat Aaronson, N. K. (1991). Methodologic issues in assessing the quality of life of cancer patients. Cancer, 67(3), 844–850.CrossRefPubMed Aaronson, N. K. (1991). Methodologic issues in assessing the quality of life of cancer patients. Cancer, 67(3), 844–850.CrossRefPubMed
7.
Zurück zum Zitat Jonsson, L., Andreasen, N., Kilander, L., Soininen, H., Waldemar, G., Nygaard, H., et al. (2006). Patient- and proxy-reported utility in Alzheimer disease using the EuroHRQoL. Alzheimer Disease and Associated Disorders, 20(1), 49–55.CrossRefPubMed Jonsson, L., Andreasen, N., Kilander, L., Soininen, H., Waldemar, G., Nygaard, H., et al. (2006). Patient- and proxy-reported utility in Alzheimer disease using the EuroHRQoL. Alzheimer Disease and Associated Disorders, 20(1), 49–55.CrossRefPubMed
8.
Zurück zum Zitat Ankri, J., Beaufils, B., Novella, J. L., Morrone, I., Guillemin, F., Jolly, D., et al. (2003). Use of the EQ-5D among patients suffering from dementia. Journal of Clinical Epidemiology, 56(11), 1055–1063.CrossRefPubMed Ankri, J., Beaufils, B., Novella, J. L., Morrone, I., Guillemin, F., Jolly, D., et al. (2003). Use of the EQ-5D among patients suffering from dementia. Journal of Clinical Epidemiology, 56(11), 1055–1063.CrossRefPubMed
9.
Zurück zum Zitat Coucill, W., Bryan, S., Bentham, P., Buckley, A., & Laight, A. (2001). EQ-5D in patients with dementia: An investigation of inter-rater agreement. Medical Care, 39(8), 760–771.CrossRefPubMed Coucill, W., Bryan, S., Bentham, P., Buckley, A., & Laight, A. (2001). EQ-5D in patients with dementia: An investigation of inter-rater agreement. Medical Care, 39(8), 760–771.CrossRefPubMed
10.
Zurück zum Zitat Naglie, G., Tomlinson, G., Tansey, C., Irvine, J., Ritvo, P., Black, S. E., et al. (2006). Utility-based quality of life measures in Alzheimer’s disease. Quality of Life Research, 15(4), 631–643.CrossRefPubMed Naglie, G., Tomlinson, G., Tansey, C., Irvine, J., Ritvo, P., Black, S. E., et al. (2006). Utility-based quality of life measures in Alzheimer’s disease. Quality of Life Research, 15(4), 631–643.CrossRefPubMed
11.
Zurück zum Zitat Vogel, A., Mortensen, E. L., Hasselbalch, S. G., Andersen, B. B., & Waldemar, G. (2006). Patient versus informant reported quality of life in the earliest phases of Alzheimer’s disease. International Journal of Geriatric Psychiatry, 21(12), 1132–1138.CrossRefPubMed Vogel, A., Mortensen, E. L., Hasselbalch, S. G., Andersen, B. B., & Waldemar, G. (2006). Patient versus informant reported quality of life in the earliest phases of Alzheimer’s disease. International Journal of Geriatric Psychiatry, 21(12), 1132–1138.CrossRefPubMed
12.
Zurück zum Zitat Long, K., Sudha, S., & Mutran, E. J. (1998). Elder-proxy agreement concerning the functional status and medical history of the older person: The impact of caregiver burden and depressive symptomatology. Journal of the American Geriatrics Society, 46(9), 1103–1111.PubMed Long, K., Sudha, S., & Mutran, E. J. (1998). Elder-proxy agreement concerning the functional status and medical history of the older person: The impact of caregiver burden and depressive symptomatology. Journal of the American Geriatrics Society, 46(9), 1103–1111.PubMed
13.
Zurück zum Zitat Pruchno, R. A., Burant, C. J., & Peters, N. D. (1997). Typologies of caregiving families: Family congruence and individual well-being. Gerontologist, 37(2), 157–167.PubMed Pruchno, R. A., Burant, C. J., & Peters, N. D. (1997). Typologies of caregiving families: Family congruence and individual well-being. Gerontologist, 37(2), 157–167.PubMed
14.
Zurück zum Zitat Rebollo, P., Alvarez-Ude, F., Valdes, C., & Estebanez, C. (2004). Different evaluations of the health related quality of life in dialysis patients. Journal of Nephrology, 17(6), 833–840.PubMed Rebollo, P., Alvarez-Ude, F., Valdes, C., & Estebanez, C. (2004). Different evaluations of the health related quality of life in dialysis patients. Journal of Nephrology, 17(6), 833–840.PubMed
15.
Zurück zum Zitat Zanetti, O., Geroldi, C., Frisoni, G. B., Bianchetti, A., & Trabucchi, M. (1999). Contrasting results between caregiver’s report and direct assessment of activities of daily living in patients affected by mild and very mild dementia: The contribution of the caregiver’s personal characteristics. Journal of the American Geriatrics Society, 47(2), 196–202.PubMed Zanetti, O., Geroldi, C., Frisoni, G. B., Bianchetti, A., & Trabucchi, M. (1999). Contrasting results between caregiver’s report and direct assessment of activities of daily living in patients affected by mild and very mild dementia: The contribution of the caregiver’s personal characteristics. Journal of the American Geriatrics Society, 47(2), 196–202.PubMed
16.
Zurück zum Zitat Rothman, M. L., Hedrick, S. C., Bulcroft, K. A., Hickam, D. H., & Rubenstein, L. Z. (1991). The validity of proxy-generated scores as measures of patient health status. Medical Care, 29(2), 115–124.CrossRefPubMed Rothman, M. L., Hedrick, S. C., Bulcroft, K. A., Hickam, D. H., & Rubenstein, L. Z. (1991). The validity of proxy-generated scores as measures of patient health status. Medical Care, 29(2), 115–124.CrossRefPubMed
17.
Zurück zum Zitat Sands, L. P., Ferreira, P., Stewart, A. L., Brod, M., & Yaffe, K. (2004). What explains differences between dementia patients’ and their caregivers’ ratings of patients’ quality of life? American Journal of Geriatric Psychiatry, 12(3), 272–280.PubMed Sands, L. P., Ferreira, P., Stewart, A. L., Brod, M., & Yaffe, K. (2004). What explains differences between dementia patients’ and their caregivers’ ratings of patients’ quality of life? American Journal of Geriatric Psychiatry, 12(3), 272–280.PubMed
18.
Zurück zum Zitat Lauterberg, J., Grossfeld-Schmitz, M., Ruckdaschel, S., Neubauer, S., Mehlig, H., Gaudig, M., et al. (2007). IDA project–concept and implementation of a cluster-randomized trial on dementia management in a general practice setting. Zeitschrift für ärztliche Fortbildung und Qualitätssicherung, 101(1), 21–26.CrossRefPubMed Lauterberg, J., Grossfeld-Schmitz, M., Ruckdaschel, S., Neubauer, S., Mehlig, H., Gaudig, M., et al. (2007). IDA project–concept and implementation of a cluster-randomized trial on dementia management in a general practice setting. Zeitschrift für ärztliche Fortbildung und Qualitätssicherung, 101(1), 21–26.CrossRefPubMed
19.
Zurück zum Zitat Lubke, N., Meinck, M., & Von Renteln-Kruse, W. (2004). The Barthel index in geriatrics. A context analysis for the Hamburg classification manual. Zeitschrift für Gerontologie und Geriatrie, 37(4), 316–326.CrossRefPubMed Lubke, N., Meinck, M., & Von Renteln-Kruse, W. (2004). The Barthel index in geriatrics. A context analysis for the Hamburg classification manual. Zeitschrift für Gerontologie und Geriatrie, 37(4), 316–326.CrossRefPubMed
20.
Zurück zum Zitat Wahle, M., Haller, S., & Spiegel, R. (1996). Validation of the NOSGER (Nurses’ Observation Scale for Geriatric Patients): Reliability and validity of a caregiver rating instrument. International Psychogeriatrics, 8(4), 525–547.CrossRefPubMed Wahle, M., Haller, S., & Spiegel, R. (1996). Validation of the NOSGER (Nurses’ Observation Scale for Geriatric Patients): Reliability and validity of a caregiver rating instrument. International Psychogeriatrics, 8(4), 525–547.CrossRefPubMed
21.
Zurück zum Zitat Greiner, W., Claes, C., Busschbach, J. J., & Graf von der Schulenburg, J. M. (2004). Validating the EQ-5D with time trade off for the German population. The European Journal of Health Economics, 6(2), 124–130.CrossRef Greiner, W., Claes, C., Busschbach, J. J., & Graf von der Schulenburg, J. M. (2004). Validating the EQ-5D with time trade off for the German population. The European Journal of Health Economics, 6(2), 124–130.CrossRef
22.
Zurück zum Zitat Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189–198.CrossRefPubMed Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189–198.CrossRefPubMed
23.
Zurück zum Zitat Gräßel, E., Chiu, T., & Oliver, R. (2003). Development and validation of the Burden scale for family caregivers (BSFC). Toronto: COTA Comprehensive Rehabilitation and Mental Health Services. Gräßel, E., Chiu, T., & Oliver, R. (2003). Development and validation of the Burden scale for family caregivers (BSFC). Toronto: COTA Comprehensive Rehabilitation and Mental Health Services.
24.
Zurück zum Zitat Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987). A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. Journal of Chronic Diseases, 40(5), 373–383.CrossRefPubMed Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987). A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. Journal of Chronic Diseases, 40(5), 373–383.CrossRefPubMed
25.
Zurück zum Zitat Andersen, C. K., Wittrup-Jensen, K. U., Lolk, A., Andersen, K., & Kragh-Sorensen, P. (2004). Ability to perform activities of daily living is the main factor affecting quality of life in patients with dementia. Health and Quality of Life Outcomes, 2(1), 52.CrossRefPubMed Andersen, C. K., Wittrup-Jensen, K. U., Lolk, A., Andersen, K., & Kragh-Sorensen, P. (2004). Ability to perform activities of daily living is the main factor affecting quality of life in patients with dementia. Health and Quality of Life Outcomes, 2(1), 52.CrossRefPubMed
26.
Zurück zum Zitat Fuh, J. L., & Wang, S. J. (2008). Cost-effectiveness analysis of donepezil for mild to moderate Alzheimer’s disease in Taiwan. Int J Geriatr Psychiatry, 23(1), 73–78.CrossRefPubMed Fuh, J. L., & Wang, S. J. (2008). Cost-effectiveness analysis of donepezil for mild to moderate Alzheimer’s disease in Taiwan. Int J Geriatr Psychiatry, 23(1), 73–78.CrossRefPubMed
27.
Zurück zum Zitat Ikeda, S., Yamada, Y., & Ikegami, N. (2002). Economic evaluation of donepezil treatment for Alzheimer’s disease in Japan. Dementia and Geriatric Cognitive Disorders, 13(1), 33–39.CrossRefPubMed Ikeda, S., Yamada, Y., & Ikegami, N. (2002). Economic evaluation of donepezil treatment for Alzheimer’s disease in Japan. Dementia and Geriatric Cognitive Disorders, 13(1), 33–39.CrossRefPubMed
28.
Zurück zum Zitat Teipel, S. J., Ewers, M., Reisig, V., Schweikert, B., Hampel, H., & Happich, M. (2007). Long-term cost-effectiveness of donepezil for the treatment of Alzheimer’s disease. European Archives of Psychiatry and Clinical Neuroscience, 257(6), 330–336.CrossRefPubMed Teipel, S. J., Ewers, M., Reisig, V., Schweikert, B., Hampel, H., & Happich, M. (2007). Long-term cost-effectiveness of donepezil for the treatment of Alzheimer’s disease. European Archives of Psychiatry and Clinical Neuroscience, 257(6), 330–336.CrossRefPubMed
29.
Zurück zum Zitat Landis, J. R., & Koch, G. G. (1977). The measurement of observer agreement for categorical data. Biometrics, 33(1), 159–174.CrossRefPubMed Landis, J. R., & Koch, G. G. (1977). The measurement of observer agreement for categorical data. Biometrics, 33(1), 159–174.CrossRefPubMed
30.
Zurück zum Zitat Shrout, P. E., & Fleiss, J. L. (1979). Intraclass correlations: Uses in assessing rater reliability. Psychological Bulletin, 86(2), 420–428.CrossRefPubMed Shrout, P. E., & Fleiss, J. L. (1979). Intraclass correlations: Uses in assessing rater reliability. Psychological Bulletin, 86(2), 420–428.CrossRefPubMed
31.
Zurück zum Zitat McGraw, K. O., & Wong, S. P. (1996). Forming inferences about some intraclass correlation coefficients. Psychological Methods, 1(1), 30–46.CrossRef McGraw, K. O., & Wong, S. P. (1996). Forming inferences about some intraclass correlation coefficients. Psychological Methods, 1(1), 30–46.CrossRef
32.
Zurück zum Zitat Scientific Advisory Committee of the Medical Outcomes Trust. (2002). Assessing health status and quality-of-life instruments: Attributes and review criteria. Quality of Life Research, 11(3), 193–205.CrossRef Scientific Advisory Committee of the Medical Outcomes Trust. (2002). Assessing health status and quality-of-life instruments: Attributes and review criteria. Quality of Life Research, 11(3), 193–205.CrossRef
34.
Zurück zum Zitat Krabbe, P. F., Stouthard, M. E., Essink-Bot, M. L., & Bonsel, G. J. (1999). The effect of adding a cognitive dimension to the EuroHRQoL multiattribute health-status classification system. Journal of Clinical Epidemiology, 52(4), 293–301.CrossRefPubMed Krabbe, P. F., Stouthard, M. E., Essink-Bot, M. L., & Bonsel, G. J. (1999). The effect of adding a cognitive dimension to the EuroHRQoL multiattribute health-status classification system. Journal of Clinical Epidemiology, 52(4), 293–301.CrossRefPubMed
35.
Zurück zum Zitat Wolfs, C. A., Dirksen, C. D., Kessels, A., Willems, D. C., Verhey, F. R., & Severens, J. L. (2007). Performance of the EQ-5D and the EQ-5D + C in elderly patients with cognitive impairments. Health and Quality of Life Outcomes, 5, 33.CrossRefPubMed Wolfs, C. A., Dirksen, C. D., Kessels, A., Willems, D. C., Verhey, F. R., & Severens, J. L. (2007). Performance of the EQ-5D and the EQ-5D + C in elderly patients with cognitive impairments. Health and Quality of Life Outcomes, 5, 33.CrossRefPubMed
36.
Zurück zum Zitat Happich, M., Schweikert, B., & Muhlbacher, A. (2005). Cost-effectiveness of galantamine in a german context. Psychiatrische Praxis, 32(3), 142–150.CrossRefPubMed Happich, M., Schweikert, B., & Muhlbacher, A. (2005). Cost-effectiveness of galantamine in a german context. Psychiatrische Praxis, 32(3), 142–150.CrossRefPubMed
37.
Zurück zum Zitat Tamim, H., McCusker, J., & Dendukuri, N. (2002). Proxy reporting of quality of life using the EQ-5D. Medical Care, 40(12), 1186–1195.CrossRefPubMed Tamim, H., McCusker, J., & Dendukuri, N. (2002). Proxy reporting of quality of life using the EQ-5D. Medical Care, 40(12), 1186–1195.CrossRefPubMed
38.
Zurück zum Zitat Calman, K. C. (1984). Quality of life in cancer patients—an hypothesis. Journal of Medical Ethics, 10(3), 124–127.CrossRefPubMed Calman, K. C. (1984). Quality of life in cancer patients—an hypothesis. Journal of Medical Ethics, 10(3), 124–127.CrossRefPubMed
39.
Zurück zum Zitat Dolan, P., & Kahneman, D. (2008). Interpretations of utility and their implications for the valuation of health. The Economic Journal, 118, 215–234. Dolan, P., & Kahneman, D. (2008). Interpretations of utility and their implications for the valuation of health. The Economic Journal, 118, 215–234.
40.
Zurück zum Zitat Greiner, W., Claes, C., Busschbach, J. J., & Graf von der Schulenburg, J. M. (2005). Validating the EQ-5D with time trade off for the German population. European Journal of Health Economics, 6(2), 124–130.CrossRefPubMed Greiner, W., Claes, C., Busschbach, J. J., & Graf von der Schulenburg, J. M. (2005). Validating the EQ-5D with time trade off for the German population. European Journal of Health Economics, 6(2), 124–130.CrossRefPubMed
41.
Zurück zum Zitat Hanmer, J., Hays, R. D., & Fryback, D. G. (2007). Mode of administration is important in US national estimates of health-related quality of life. Medical Care, 45(12), 1171–1179.CrossRefPubMed Hanmer, J., Hays, R. D., & Fryback, D. G. (2007). Mode of administration is important in US national estimates of health-related quality of life. Medical Care, 45(12), 1171–1179.CrossRefPubMed
42.
Zurück zum Zitat Pickard, A. S., & Knight, S. J. (2005). Proxy evaluation of health-related quality of life: A conceptual framework for understanding multiple proxy perspectives. Medical Care, 43(5), 493–499.CrossRefPubMed Pickard, A. S., & Knight, S. J. (2005). Proxy evaluation of health-related quality of life: A conceptual framework for understanding multiple proxy perspectives. Medical Care, 43(5), 493–499.CrossRefPubMed
43.
Zurück zum Zitat Gundy, C. M., & Aaronson, N. K. (2008). The influence of proxy perspective on patient–proxy agreement in the evaluation of health-related quality of life: An empirical study. Medical Care, 46(2), 209–216.CrossRefPubMed Gundy, C. M., & Aaronson, N. K. (2008). The influence of proxy perspective on patient–proxy agreement in the evaluation of health-related quality of life: An empirical study. Medical Care, 46(2), 209–216.CrossRefPubMed
Metadaten
Titel
Psychometric properties of the EQ-5D in a study of people with mild to moderate dementia
verfasst von
Simone Kunz
Publikationsdatum
01.04.2010
Verlag
Springer Netherlands
Erschienen in
Quality of Life Research / Ausgabe 3/2010
Print ISSN: 0962-9343
Elektronische ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-010-9600-1

Weitere Artikel der Ausgabe 3/2010

Quality of Life Research 3/2010 Zur Ausgabe